Published on
Jan 17, 2025
Research Progress of NK Cells in Glioblastoma Treatment
Introduction Glioblastoma (GBM) is the most common malignant tumor.1 The global incidence of GBM is approximately 10 cases per 100,000 people. The median survival for GBM is approximately 12 months, with estimated survival rates at 1, 2, and 5 years being …
Source:
Dove Medical Press
-
Neutral
